514 / | HD | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
|
1 | DF | DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) {29} |
183 | DF | .~ Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI {16} |
228.8 | DF | .~.~ Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) {4} |
231.2 | | .~.~.~ Morpholines (i.e., fully hydrogenated 1,4- oxazines) {5} |
231.5 | DF | .~.~.~.~> Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding {3} |
237.5 | DF | .~.~.~.~> Having -C(=X)-, wherein X is chalcogen, bonded directly to the morpholine ring |
237.8 | DF | .~.~.~.~> Nitrogen attached indirectly to the morpholine ring by acyclic nonionic bonding {2} |
238.8 | DF | .~.~.~.~> Chalcogen attached indirectly to the morpholine ring by acyclic nonionic bonding {1} |
239.5 | DF | .~.~.~.~> Carbocyclic ring attached indirectly to the morpholine ring by nonionic bonding |